debrisoquin has been researched along with Back Pain in 2 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Back Pain: Acute or chronic pain located in the posterior regions of the THORAX; LUMBOSACRAL REGION; or the adjacent regions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Skeith, KJ | 1 |
Hussain, MS | 1 |
Coutts, RT | 1 |
Ramos-Remus, C | 1 |
Avina-Zubieta, JA | 1 |
Russell, AS | 1 |
Omenn, GS | 1 |
1 review available for debrisoquin and Back Pain
Article | Year |
---|---|
Ethnic differences in reactions to drugs and xenobiotics. Susceptibility to occupational and environmental exposures to chemicals.
Topics: Acetylation; alpha 1-Antitrypsin; Anemia, Hemolytic; Aryl Hydrocarbon Hydroxylases; Asian People; Ba | 1986 |
1 trial available for debrisoquin and Back Pain
Article | Year |
---|---|
Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia.
Topics: Adult; Analgesics; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Age | 1997 |